
Zhejiang Medicine Co Ltd
SSE:600216

Intrinsic Value
The intrinsic value of one
Zhejiang Medicine Co Ltd
stock under the Base Case scenario is
21.54
CNY.
Compared to the current market price of 13.41 CNY,
Zhejiang Medicine Co Ltd
is
Undervalued by 38%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Zhejiang Medicine Co Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Zhejiang Medicine Co Ltd
Balance Sheet Decomposition
Zhejiang Medicine Co Ltd
Current Assets | 6.6B |
Cash & Short-Term Investments | 2.3B |
Receivables | 2.1B |
Other Current Assets | 2.2B |
Non-Current Assets | 7.2B |
Long-Term Investments | 248.4m |
PP&E | 6.1B |
Intangibles | 684.4m |
Other Non-Current Assets | 137.7m |
Free Cash Flow Analysis
Zhejiang Medicine Co Ltd
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
Zhejiang Medicine Co Ltd
Revenue
|
9.4B
CNY
|
Cost of Revenue
|
-5.3B
CNY
|
Gross Profit
|
4.1B
CNY
|
Operating Expenses
|
-2.6B
CNY
|
Operating Income
|
1.5B
CNY
|
Other Expenses
|
-80.1m
CNY
|
Net Income
|
1.5B
CNY
|
Profitability Score
Profitability Due Diligence
Zhejiang Medicine Co Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Score
Zhejiang Medicine Co Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Zhejiang Medicine Co Ltd's solvency score is 82/100. The higher the solvency score, the more solvent the company is.

Score
Zhejiang Medicine Co Ltd's solvency score is 82/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Zhejiang Medicine Co Ltd
According to Wall Street analysts, the average 1-year price target for
Zhejiang Medicine Co Ltd
is 17.34 CNY
with a low forecast of 16.67 CNY and a high forecast of 18.38 CNY.
Dividends
Current shareholder yield for Zhejiang Medicine Co Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Zhejiang Medicine Co Ltd
stock under the Base Case scenario is
21.54
CNY.
Compared to the current market price of 13.41 CNY,
Zhejiang Medicine Co Ltd
is
Undervalued by 38%.